Send me a link:

*Text messaging rates may apply.

 Dow Down 1.88% Nasdaq Down 2.09%

More On LRUSF

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Lorus Therapeutics Inc. (LRUSF)

-Other OTC
0.44 Down 0.01(1.46%) Jul 31
Prev Close:0.45
Open:0.44
Bid:N/A
Ask:N/A
1y Target Est:1.86
Beta:-0.11
Next Earnings Date:N/A
Day's Range:0.44 - 0.44
52wk Range:0.17 - 0.93
Volume:525
Avg Vol (3m):9,022
Market Cap:61.09M
P/E (ttm):N/A
EPS (ttm):-0.15
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for LRUSF at this time.

Comparison

Symbol% ChgMkt Cap
LRUSFDown 1.46%61.09M
BMYDown 0.98%83.92B
ISISDown 2.79%3.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (May-15) :-0.13
Quarterly EPS Est (Aug-14) :-0.03
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Lorus Therapeutics Inc., a biopharmaceutical company, is engaged in the discovery, research, and development of novel anticancer therapies in Canada. The company’s pipeline of cancer drug candidates includes small molecule therapies and immun... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback